Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INOTERSEN for Amyloidosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 46 adverse event reports in the FDA FAERS database where INOTERSEN was used for Amyloidosis.

Most Reported Side Effects for INOTERSEN

Side Effect Reports % Deaths Hosp.
Platelet count decreased 334 19.5% 18 86
Protein urine present 269 15.7% 7 48
Glomerular filtration rate decreased 264 15.4% 6 54
Urine protein/creatinine ratio increased 249 14.5% 7 51
Blood creatinine increased 214 12.5% 6 46
Fatigue 198 11.6% 16 78
Bacterial test positive 193 11.3% 5 31
Urine abnormality 184 10.7% 5 30
Nausea 152 8.9% 10 67
Malaise 145 8.5% 14 79
Diarrhoea 135 7.9% 9 60
Asthenia 134 7.8% 15 73
Urinary casts 127 7.4% 3 18
Pain 124 7.2% 7 63
White blood cells urine positive 124 7.2% 3 18

Other Indications for INOTERSEN

Hereditary neuropathic amyloidosis (1,396) Product used for unknown indication (179) Polyneuropathy (62) Familial amyloidosis (52) Cardiac amyloidosis (12) Acquired attr amyloidosis (10) Amyloidosis senile (7)

Other Drugs Used for Amyloidosis

TAFAMIDIS (2,264) LENALIDOMIDE (1,315) BORTEZOMIB (1,044) DEXAMETHASONE (932) TAFAMIDIS MEGLUMINE (641) CYCLOPHOSPHAMIDE (585) POMALIDOMIDE (477) DARATUMUMAB (417) IXAZOMIB (168) MELPHALAN (145)

Related Pages

INOTERSEN Full Profile All Amyloidosis Drugs INOTERSEN Demographics INOTERSEN Timeline